EGFR and hepatocellular carcinoma: Mechanistically, miR-206 inhibits liver CSC expansion by suppressing dedifferentiation of HCC cells and attenuating self-renewal of liver CSCs through direct targeting of Epidermal Growth Factor Receptor (EGFR) [86].